LAXAI

Hyderabad, India Founded: 2007 • Age: 19 yrs
Drug discovery and development services are provided by LAXAI.
Annual revenue $15.6M Latest available
Total funding - 1 rounds
Employees 345 Tracked headcount
Investors 1 Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About LAXAI

LAXAI is a company based in Hyderabad (India) founded in 2007 by Vamsi Maddipatla. The company has 345 employees as of March 28, 2024. LAXAI has completed 1 acquisition, including OSR Solutions. LAXAI offers products and services including Integrated Drug Discovery, Chemical Process Development, Manufacturing Services, and Specialty Chemicals. LAXAI operates in a competitive market with competitors including Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.

  • Headquarter Hyderabad, India
  • Employees 345 as on 28 Mar, 2024
  • Founders Vamsi Maddipatla
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Laxai Life Sciences Private Limited
  • Date of Incorporation 10 Jul, 2006
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $15.63 M (USD)
    47.91
    as on Mar 31, 2023
  • Net Profit
    -$8.08 M (USD)
    -2.95
    as on Mar 31, 2023
  • EBITDA
    -$3.84 M (USD)
    17.7
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    345

    as on Mar 28, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of LAXAI

LAXAI offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, Chemical Process Development, Manufacturing Services, and Specialty Chemicals.

Product name locked
Category locked
Primary

Services for drug programs from target identification to IND filing.

Product name locked
Category locked
Locked

Optimizes routes for efficient chemical manufacturing processes.

Product name locked
Category locked
Locked

Provides supplies for pre-clinical to commercial phases.

Product name locked
Category locked
Locked

Offers custom synthesis of fine chemicals and intermediates.

People of LAXAI

Headcount 500-1000
Employee Profiles 7
Employee Profiles
People
Ranjith Reddy
Senior Executive Business Development
People
Ganesh Venkatraman
President
People
Ramesh Mullangi
Executive Vice President
People
Deepak Kumar M
Information Technology Manager

Unlock access to complete

Funding Insights of LAXAI

Investors in LAXAI

LAXAI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Signet Healthcare Partners.

All
Venture Fund
Investor Description Founded Year Domain Location
PE firm investing in North America and Europe
Locked Locked Locked
Premium access

Investor details for LAXAI

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by LAXAI

LAXAI has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OSR Solutions.

Investments
Premium access

Investment portfolio details for LAXAI

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Strategic consulting services are provided to business clients.
Locked Locked 2001 Locked
Premium access

Complete acquisition details for LAXAI

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - LAXAI

Premium access

Detailed financials for LAXAI

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Laxai Comparisons

LAXAI Primary company
Description
Drug discovery and development services are provided by LAXA...
Location
Hyderabad, India
Founded Year
2007
Annual Revenue
$15.63 M (USD)
Net Profit
-$8.08 M (USD)
EBITDA
-$3.84 M (USD)
Employees
345
As of 2024
Premium access

Peer comparison for LAXAI

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of LAXAI

LAXAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug discovery and development services for small molecules are provided.
Locked Locked Locked
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Generic drugs and clinical research services are provided globally.
Locked Locked Locked
CDMO services for pharma, biotech, and specialty ingredients are provided.
Locked Locked Locked
AI powered scientific data management and workflow automation solutions
Locked Locked Locked
Laboratory testing, clinical trial research, and biopharma services are provided.
Premium access

Detailed competitors of LAXAI

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Laxai

Premium access

Complete news archive for LAXAI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LAXAI

LAXAI was founded in 2007 and raised its 1st funding round 15 years after it was founded.

LAXAI is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Vamsi Maddipatla is the current CEO of LAXAI. They have also founded this company.

As of Mar 28, 2024, the latest employee count at LAXAI is 345.

Annual revenue of LAXAI is $15.63M as on Mar 31, 2023.

LAXAI was founded in 2007 and is headquartered in Hyderabad, India. Drug discovery and development services are offered within the pharmaceutical sector. Operations are centered on supporting research and innovation for clients in biotechnology. The company is led by Co-Founder and CEO Vamsi Maddipatla, with activities focused on advancing therapeutic solutions through structured development processes.

LAXAI's top competitors include Pharmaron, Pfizer and Lonza.

LAXAI offers Integrated Drug Discovery, Chemical Process Development, Manufacturing Services, and Specialty Chemicals.

LAXAI has made 1 acquisition, including OSR Solutions.

LAXAI has 1 investor. Key investors include Signet Healthcare Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available